Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2905285 | 1.00 | GCK (0.64) | GCKKCNH2 | |
| SCHEMBL2906672 | 0.93 | GCK (0.59) | GCKKCNH2 | |
| SCHEMBL3592160 | 0.90 | GCK (0.71) | GCKKCNH2 | |
| SCHEMBL13255188 | 0.90 | GCK (0.71) | GCKKCNH2 | |
| SCHEMBL13209629 | 0.88 | GCK (0.58) | GCKKCNH2 | |
| SCHEMBL2654672 | 0.85 | GCK (0.73) | GCKKCNH2 | |
| SCHEMBL2659800 | 0.84 | GCK (0.73) | GCKKCNH2 | |
| SCHEMBL2662601 | 0.84 | GCK (0.67) | GCKKCNH2 | |
| SCHEMBL2654104 | 0.83 | GCK (0.79) | GCKKCNH2 | |
| SCHEMBL2654767 | 0.83 | GCK (0.79) | GCKKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1992623-A1 | Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes | Astra Zeneca AB (SE) | 2008-11-19 | — | — | EP | disclosed |